Mental Health Rehabilitation Public Health Rehabilitation Programs Ketamine Therapy Ketamine Opioids Recovery Programs De-addiction Programs Public Health Policy Support Services Rehabilitation Centers Mental Health Services Prevention Strategies Buprenorphine/Naloxone Counseling De-addiction Centres Psychiatric Disorders De-addiction Services Prevention Programs Opioid Addiction De-addiction Centers Therapy Ketamine Use Opioid Crisis Drug Overdose Recovery Process Community Health Cocaine Overdose Therapeutic Communities Naltrexone Detoxification NFL Policies Counseling Programs Drug Rehabilitation Public Health Response Public Health Issues De-addiction Initiatives Prevention Methadone Pain Management Drug Counseling Mental Health Impact Support Systems Methadone Program Fentanyl Dissociative Anesthetics Behavioral Health Peer Support Services Support Programs Rehabilitation Clinics Mental Health Awareness Psychological Effects Patient Care
Charging documents outline a Park Heights drug manufacturing site linked to a tainted supply containing the animal sedative medetomidine.
